These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 21859400)
21. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease. Jaminon AMG; Dai L; Qureshi AR; Evenepoel P; Ripsweden J; Söderberg M; Witasp A; Olauson H; Schurgers LJ; Stenvinkel P Sci Rep; 2020 Apr; 10(1):6586. PubMed ID: 32313061 [TBL] [Abstract][Full Text] [Related]
22. Role of non-HLA genetic variants in end-stage renal disease. Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039 [TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Proudfoot D; Shanahan CM Nephrology (Carlton); 2006 Oct; 11(5):455-61. PubMed ID: 17014561 [TBL] [Abstract][Full Text] [Related]
24. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. Doi K; Noiri E; Nakao A; Fujita T; Kobayashi S; Tokunaga K J Am Soc Nephrol; 2006 Mar; 17(3):823-30. PubMed ID: 16421229 [TBL] [Abstract][Full Text] [Related]
25. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients. Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368 [TBL] [Abstract][Full Text] [Related]
26. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Nikolsky E; Mehran R; Turcot D; Aymong ED; Mintz GS; Lasic Z; Lansky AJ; Tsounias E; Moses JW; Stone GW; Leon MB; Dangas GD Am J Cardiol; 2004 Aug; 94(3):300-5. PubMed ID: 15276092 [TBL] [Abstract][Full Text] [Related]
27. Oxidative stress is progressively enhanced with advancing stages of CKD. Dounousi E; Papavasiliou E; Makedou A; Ioannou K; Katopodis KP; Tselepis A; Siamopoulos KC; Tsakiris D Am J Kidney Dis; 2006 Nov; 48(5):752-60. PubMed ID: 17059994 [TBL] [Abstract][Full Text] [Related]
28. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253 [TBL] [Abstract][Full Text] [Related]
29. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860 [TBL] [Abstract][Full Text] [Related]
30. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756 [TBL] [Abstract][Full Text] [Related]
31. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Buraczynska M; Ksiazek P; Zaluska W; Nowicka T; Ksiazek A Nephrol Dial Transplant; 2004 Sep; 19(9):2302-6. PubMed ID: 15299097 [TBL] [Abstract][Full Text] [Related]
32. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426 [TBL] [Abstract][Full Text] [Related]
33. Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Aveles PR; Criminácio CR; Gonçalves S; Bignelli AT; Claro LM; Siqueira SS; Nakao LS; Pecoits-Filho R Nephron Clin Pract; 2010; 116(4):c294-9. PubMed ID: 20639676 [TBL] [Abstract][Full Text] [Related]
35. A polymorphism of matrix Gla protein gene is associated with kidney stone in the Chinese Han population. Lu X; Gao B; Liu Z; Tian X; Mao X; Emmanuel N; Zhu Q; Xiao C Gene; 2012 Dec; 511(2):127-30. PubMed ID: 23046575 [TBL] [Abstract][Full Text] [Related]
36. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Cranenburg EC; Koos R; Schurgers LJ; Magdeleyns EJ; Schoonbrood TH; Landewé RB; Brandenburg VM; Bekers O; Vermeer C Thromb Haemost; 2010 Oct; 104(4):811-22. PubMed ID: 20694284 [TBL] [Abstract][Full Text] [Related]
37. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127 [TBL] [Abstract][Full Text] [Related]
38. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349 [TBL] [Abstract][Full Text] [Related]
39. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients]. Grabysa R; Cholewa M Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327 [TBL] [Abstract][Full Text] [Related]
40. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients. Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]